GALIMBERTI, SARA Statistiche

GALIMBERTI, SARA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 499 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group 1-gen-2008 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group 1-gen-2008 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma 1-gen-2010 Orciuolo, E; Buda, Gabriele; Sordi, E; Baraté, C; Galimberti, Sara; Ciancia, E; Petrini, Mario
5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM 1-gen-2008 Maurillo, L; Spagnoli, A; Gozzini, A; Cecconi, N; 2 D'Argenio, M; Lunghi, M; Rocco, S; Palumbo, G; Rivellini, F; Genuardi, M; Sibilla, S; Ferrara, F; Mele, G; Filardi, N; Sanpaolo, G; Specchia, G; Tonso, A; Santagostino, A; Voso, Mt; Balleari, E; Cassibba, B; Della Cioppa, P; Mazzone, C; Oliva, E; Ciuffreda, L; Russo, D; Galimberti, Sara; Villani, O; D'Auria, F; Di Renzo, N; D'Arco, Am
5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES : RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM 1-gen-2008 Mustop, ; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, F; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, D; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, A; Tonso, A; Santagostino A., Villani O; D'Auria, F; D'Arco, A; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V.
5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program 1-gen-2008 Musto, P; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, C; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, P; Candoni, A; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, D; Tonso, A; Santagostino, A; Rocco, S; Villani, O; D’Auria, F; D’Arco, Am; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V.
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group 1-gen-2008 Carella, Am; Nati, S; Fraternali Orcioni, G; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, P. L.
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings 1-gen-2004 Papineschi, Federico; Benedetti, E; Galimberti, Sara; Caracciolo, F; Fazzi, R; Petrini, Mario
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA 1-gen-2016 Drandi, D.; Genuardi, E; Dogliotti, I.; Sciascia, I.; Guerrini, Francesca; Mantoan, B.; Gilestro, M.; Muccio, V.; Ghione, P.; Omede, P.; Galimberti, Sara; Orsucci, L.; Cavallo, F.; Boccadoro, M.; Ladetto, M; Ferrero, S.
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 1-gen-2012 Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 1-gen-2022 Visco, C.; Marcheselli, L.; Mina, R.; Sassone, M.; Guidetti, A.; Penna, D.; Cattaneo, C.; Bonuomo, V.; Busca, A.; Ferreri, A. J. M.; Bruna, R.; Petrucci, L.; Cairoli, R.; Salvini, M.; Bertu, L.; Ladetto, M.; Pilerci, S.; Pinto, A.; Ramadan, S.; Marchesi, F.; Cavo, M.; Arcaini, L.; Coviello, E.; Romano, A.; Musto, P.; Massaia, M.; Fracchiolla, N.; Marchetti, M.; Scattolin, A.; Tisi, M. C.; Cuneo, A.; Porta, M. D.; Trentin, L.; Turrini, M.; Gherlinzoni, F.; Tafuri, A.; Galimberti, S.; Bocchia, M.; Cardinali, V.; Cilloni, D.; Corso, A.; Armiento, D.; Rigacci, L.; La Barbera, E. O.; Gambacorti-Passerini, C.; Visani, G.; Vallisa, D.; Venditti, A.; Selleri, C.; Conconi, A.; Tosi, P.; Lanza, F.; Candoni, A.; Krampera, M.; Corradini, P.; Passamonti, F.; Merli, F.
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy 1-gen-2022 Benedetti, Edoardo; Mavilia, Fabrizio; Baratè, Claudia; Bramanti, Emilia; Morganti, Riccardo; Cervetti, Giulia; Capochiani, Enrico; Bruno, Benedetto; Pelosini, Matteo; Stella, Salvatore Massimo; Galimberti, Sara
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation 1-gen-2020 Dragani, Matteo; Rege Cambrin, Giovanna; Berchialla, Paola; Dogliotti, Irene; Rosti, Gianantonio; Castagnetti, Fausto; Capodanno, Isabella; Martino, Bruno; Cerrano, Marco; Ferrero, Dario; Gambacorti-Passerini, Carlo; Crugnola, Monica; Elena, Chiara; Breccia, Massimo; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Gozzini, Antonella; Bocchia, Monica; Lunghi, Francesca; Cedrone, Michele; Sgherza, Nicola; Luciano, Luigia; Russo, Sabina; Santoro, Marco; Giai, Valentina; Caocci, Giovanni; Levato, Luciano; Abruzzese, Elisabetta; Sora, Federica; Saglio, Giuseppe; Fava, Carmen
A therapy resistant myelodysplastic syndrome characterized by the presence of the rare reciprocal translocation t(3;12)(q26.2;p13) 1-gen-2007 Orciuolo, E; Buda, Gabriele; Cecconi, N; Galimberti, Sara; Petrini, Mario
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib 1-gen-2010 Carulli, Giovanni; Cannizzo, Elisa; Ottaviano, Virginia; Cervetti, Giulia; Buda, Gabriele; Galimberti, Sara; Baratè, Claudia; Marini, Alessandra; Petrini, Mario
ACCURACY AND PRECISION OF RESULTS AFTER IMPLEMENTATION OF INTERNATIONAL SCALE TO EVALUATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA PATIENTS COORDINATED ON BEHALF OF GIMEMA-CML WP 1-gen-2009 Quarantelli, F; Izzo, B; Amabile, M; Gottardi, E; Albano, F; Spinelli, O; Vigneri, P; Gozzini, A; Garuti, A; Pezzetti, L; Colnaghi, F; Monne, M; Santoro, A; Bernasconi, P; Di Ianni, M; Donati, M; Giannini, B; Mammi’, C; Diverio, D; Divona M., D; De Matteis, G; Rossi, G; Culurgioni, F; Minervini, M; Galimberti, Sara; Nicci, C; Saglio, G; Martinelli, G; Pane, F.
Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor 1-gen-2006 Carulli, Giovanni; Mattii, Letizia; Azzara', Antonio; Brizzi, S; Galimberti, Sara; Zucca, A; Benedetti, E; Petrini, Mario
Activation of the Zinc-sensing receptor GPR39 promotes T cell reconstitution after hematopoietic cell transplant in mice 1-gen-2022 Iovino, Lorenzo; Cooper, Kirsten; Deroos, Paul; Kinsella, Sinead; Evandy, Cindy Anggelica; Ugrai, Tamas; Mazziotta, Francesco; Ensbey, Kathleen S; Granadier, David; Hopwo, Kayla; Smith, Colton W; Gagnon, Alex; Galimberti, Sara; Petrini, Mario; Hill, Geoffrey R; Dudakov, Jarrod A
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma 1-gen-2008 Focosi, Daniele; Cecconi, N; Boni, G; Orciuolo, E; Galimberti, Sara; Petrini, Mario
Acute myeloid leukaemia after treatment with 90Y-ibritumomab tiuxetan for follicular lymphoma 1-gen-2008 Focosi, Daniele; Cecconi, Nadia; Boni, Giuseppe; Orciuolo, Enrico; Galimberti, Sara; Petrini, Mario